San Francisco software and agency platform where consumers buy life insurance online in 10 minutes without medical exams; Ethos earns commissions and is not an insurer

Becoming profitable first, then listing, would give a 10-year-old insurtech the credibility to win business from century-old insurance carriers

Over $400 million in venture capital raised before the IPO

Ethos co-founders Peter Colis and Lingke Wang built a three-sided platform for consumers, independent agents and carriers. Colis says that when they launched there were eight or nine similar life insurtechs with similar Series A funding.

As cheap capital ended in 2022, Colis says Ethos got serious about profitability, and per its IPO documents it was profitable by mid-2023 with year-over-year revenue growth above 50% since. In the nine months to September 30, 2025 it had almost $278M revenue and just under $46.6M net income. Peers fared worse: Policygenius was acquired by PE-backed Zinnia in 2023 and Health IQ filed for bankruptcy that year.

Ethos and selling shareholders sold 10.5 million shares at $19 under the ticker LIFE, raising about $200M. The stock closed day one at $16.85, 11% below the IPO price, a market cap of about $1.1B versus $2.7B in its July 2021 round.

Cheap capital and easy fundraising ended in 2022, so Ethos prioritised profitability

Peers such as Policygenius and Health IQ were sold or went bankrupt in 2023

Major insurance carriers are over a century old, so a public listing signals staying power

Revenue growth above 50% year over year gave a growth story alongside profit

Going public after reaching profitability gave Ethos staying power its peers lacked, even though the IPO valued it well below its 2021 private round.

As of 2026-01-29 Ethos was a Nasdaq-listed company worth about $1.1B after a first day 11% below its IPO price. TechCrunch described the listing as a bellwether for the 2026 IPO cycle. Sequoia and Accel did not sell shares in the IPO.

FOLLOW THE EVIDENCE

The sources

  1. How Sequoia-backed Ethos reached the public market while rivals fell short techcrunch.com